MicroPort Scientific Corporation, a leading medical equipment manufacturer, received registration approval for its Hercules Low Profile Thoracic Stent Graft from the Indian Central Drugs Standard Control Organization (CDSCO). This approval clears the entry of the first Endovastec product for marketing in India.
Terumo Corporation, a medical equipment leader, announced that it received FDA approval to commercialize the Thoraflex Hybrid Frozen Elephant Trunk (FET) device in the US. It is a single-use medical equipment collective with a Gelweave polyester graft and Nitinol self-expanding stent-graft in instances of aneurysm or dissection.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5073
Published Date: Jun 25, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
A significant percentage of tobacco use in both developing and developed nations, the rising geriatric population, and others are the major factors driving the market growth.
The market is anticipated to attain a CAGR of 5.5% over the forecast period, i.e., 2023 â€“ 2035.
The major players in the market are W. L. Gore & Associates, Inc., MicroPort Scientific Corporation, LLC, Terumo Corporation, Boston Scientific Corporation, and others.
The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by type, product type, treatment type, and by region.
The abdominal aortic aneurysm (AAA) segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
High research and development activities are estimated to be the growth-hindering factors for market expansion.
The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.